Top Markets
Coin of the day
Graphite Bio, Inc. Graphite Bio, Inc.

Graphite Bio, Inc.

GRPH
Rangering i aksjer #12751
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to... Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.
Aksjekurs
$22.26
Sist synkronisert: 2024-03-22
Markedsverdi
$553.40M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Graphite Bio, Inc. (GRPH)

Kategori

Historikk for aksjesplitt for Graphite Bio, Inc. (GRPH)
Aksjen Graphite Bio, Inc. (symbol: GRPH) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 31, 2026.
Én GRPH-aksje kjøpt før Aug 31, 2026 tilsvarer i dag 0 GRPH-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH